Nowadays, numerous facilities combine the early ultrasound scan and nuchal scan into a single procedure.

NICE guidelines recommend 10 antenatal visits for first pregnancies and 7 for subsequent pregnancies if uncomplicated. The purpose of each visit is outlined, including booking visits, scans, screening for Down’s syndrome, routine care for blood pressure and urine, and discussions about labour and birth plans. Rhesus negative women are offered anti-D prophylaxis at 28 and 34 weeks. The guidelines also recommend discussing options for prolonged pregnancy at 41 weeks.

Despite the absence of symptoms, the patient’s blood pressure remains elevated at a level exceeding 160/100 mmHg, and there is also significant proteinuria, despite receiving labetalol treatment. As a result, emergency admission is necessary to monitor and manage the hypertension in a controlled setting. If there is no improvement, delivery may be considered as an option.

Hypertension during pregnancy is a common occurrence that requires careful management. In normal pregnancies, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, in cases of hypertension during pregnancy, the systolic blood pressure is usually above 140 mmHg or the diastolic blood pressure is above 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from the initial readings may also indicate hypertension.

There are three categories of hypertension during pregnancy: pre-existing hypertension, pregnancy-induced hypertension (PIH), and pre-eclampsia. Pre-existing hypertension refers to a history of hypertension before pregnancy or elevated blood pressure before 20 weeks gestation. PIH occurs in the second half of pregnancy and resolves after birth. Pre-eclampsia is characterized by hypertension and proteinuria, and may also involve edema.

The management of hypertension during pregnancy involves the use of antihypertensive medications such as labetalol, nifedipine, and hydralazine. In cases of pre-existing hypertension, ACE inhibitors and angiotensin II receptor blockers should be stopped immediately and alternative medications should be prescribed. Women who are at high risk of developing pre-eclampsia should take aspirin from 12 weeks until the birth of the baby. It is important to carefully monitor blood pressure and proteinuria levels during pregnancy to ensure the health of both the mother and the baby.

Benefits and Risks of Oral Contraceptives

Oral contraceptives, also known as birth control pills, are a popular form of contraception for women. They contain synthetic hormones that prevent pregnancy by inhibiting ovulation, thickening cervical mucus, and altering the lining of the uterus. While oral contraceptives have many benefits, they also carry some risks.

Venous Thrombosis: The estrogen component of oral contraceptives can activate the blood-clotting mechanism, increasing the risk of venous thrombosis. However, low-dose oral contraceptives are associated with a lower risk of thromboembolism.

Benign Breast Disease: Oral contraceptives can prevent benign breast disease, but their association with breast cancer in young women is controversial. While some studies suggest a slightly increased risk of breast cancer, the risk is small and the resulting tumors spread less aggressively than usual.

Functional Ovarian Cysts: Oral contraceptives suppress ovarian stimulation, reducing the risk of developing functional ovarian cysts.

Carcinoma of the Ovary or Uterus: Oral contraceptives can prevent epithelial ovarian and endometrial carcinoma. They are associated with a 40% reduced risk of malignant and borderline ovarian epithelial cancer and a 50% reduction in the risk of endometrial adenocarcinoma.

Pelvic Inflammatory Disease: Oral contraceptives can prevent the development of pelvic inflammatory disease.

Overall, oral contraceptives are reliable and reversible, reduce menstrual symptoms, and lower the risk of certain cancers and pelvic inflammatory disease. However, they carry some risks, including an increased risk of venous thrombosis and a controversial association with breast cancer. Women should discuss the benefits and risks of oral contraceptives with their healthcare provider to determine if they are a suitable form of contraception.

In cases where a pregnant woman is exposed to chickenpox and her immunity status is uncertain, it is recommended to conduct a blood test to check for varicella antibodies. If she is found to be not immune and is over 20 weeks pregnant, either VZIG or aciclovir can be given. However, VZIG is the only option for those under 20 weeks pregnant and not immune. It is important to note that VZIG is effective up to 10 days post-exposure, so there is no need to administer it immediately after the blood test. Prescribing medication without confirming the patient’s immunity status is not recommended. Similarly, reassuring the patient and sending her away without following proper prophylaxis protocol is not appropriate. It is also important to note that the varicella-zoster vaccine is not currently part of the UK’s vaccination schedule and does not play a role in the management of pregnant women.

Chickenpox exposure in pregnancy can pose risks to both the mother and fetus, including fetal varicella syndrome. Post-exposure prophylaxis (PEP) with varicella-zoster immunoglobulin (VZIG) or antivirals should be given to non-immune pregnant women, with timing dependent on gestational age. If a pregnant woman develops chickenpox, specialist advice should be sought and oral aciclovir may be given if she is ≥ 20 weeks and presents within 24 hours of onset of the rash.

To confirm ovulation in patients struggling to conceive, a serum progesterone level should be taken 7 days prior to the expected next period. This timing coincides with ovulation and is the most accurate way to confirm it. Taking the test 14 days before the next expected period or on the first day of the next period would not be timed correctly. It is also important to note that the timing of intercourse does not affect the confirmation of ovulation through serum progesterone testing.

Infertility is a common issue that affects approximately 1 in 7 couples. It is important to note that around 84% of couples who have regular sexual intercourse will conceive within the first year, and 92% within the first two years. The causes of infertility can vary, with male factor accounting for 30%, unexplained causes accounting for 20%, ovulation failure accounting for 20%, tubal damage accounting for 15%, and other causes accounting for the remaining 15%.

When investigating infertility, there are some basic tests that can be done. These include a semen analysis and a serum progesterone test. The serum progesterone test is done 7 days prior to the expected next period, typically on day 21 for a 28-day cycle. The interpretation of the serum progesterone level is as follows: if it is less than 16 nmol/l, it should be repeated and if it remains consistently low, referral to a specialist is necessary. If the level is between 16-30 nmol/l, it should be repeated, and if it is greater than 30 nmol/l, it indicates ovulation.

It is important to counsel patients on lifestyle factors that can impact fertility. This includes taking folic acid, maintaining a healthy BMI between 20-25, and advising regular sexual intercourse every 2 to 3 days. Additionally, patients should be advised to quit smoking and limit alcohol consumption to increase their chances of conceiving.

Breastfeeding is classified as UKMEC category 4 if done for less than 6 weeks after giving birth, but it is categorized as UKMEC category 2 if done after this period.

The decision to prescribe the combined oral contraceptive pill is now based on the UK Medical Eligibility Criteria (UKMEC), which categorizes potential contraindications and cautions on a four-point scale. UKMEC 1 indicates no restrictions for use, while UKMEC 2 suggests that the benefits outweigh the risks. UKMEC 3 indicates that the disadvantages may outweigh the advantages, and UKMEC 4 represents an unacceptable health risk. Examples of UKMEC 3 conditions include controlled hypertension, a family history of thromboembolic disease in first-degree relatives under 45 years old, and current gallbladder disease. Examples of UKMEC 4 conditions include a history of thromboembolic disease or thrombogenic mutation, breast cancer, and uncontrolled hypertension. Diabetes mellitus diagnosed over 20 years ago is classified as UKMEC 3 or 4 depending on severity. In 2016, breast feeding between 6 weeks and 6 months postpartum was changed from UKMEC 3 to UKMEC 2.

Understanding Chorioamnionitis

Chorioamnionitis is a serious medical condition that can affect both the mother and the foetus during pregnancy. It is caused by a bacterial infection that affects the amniotic fluid, membranes, and placenta. This condition is considered a medical emergency and can be life-threatening if not treated promptly. It is more likely to occur when the membranes rupture prematurely, but it can also happen when the membranes are still intact.

Prompt delivery of the foetus is crucial in treating chorioamnionitis, and a cesarean section may be necessary. Intravenous antibiotics are also administered to help fight the infection. This condition affects up to 5% of all pregnancies, and it is important for pregnant women to be aware of the symptoms and seek medical attention immediately if they suspect they may have chorioamnionitis.

If blood glucose targets are not achieved through diet and metformin in gestational diabetes, insulin should be introduced.

The patient in this case was diagnosed with gestational diabetes during their initial appointment. Despite attempting metformin, their fasting and two-hour post glucose challenge blood glucose levels remain elevated above the normal range. Therefore, insulin should be added to their treatment plan. Choosing to make no changes to their treatment plan is not the correct answer, as this could lead to increased risks for the fetus, such as the development of polyhydramnios or macrosomia. While referral for dietary and exercise regimens may be considered, this is likely to be a first-line intervention, and further escalation of medical therapy is necessary for the health of the fetus. Increasing the dose of metformin is not the correct answer, as the NICE guidelines recommend starting insulin when initial interventions have been unsuccessful. Waiting two weeks to repeat the results would delay necessary treatment intensification, which is required at the current clinic appointment.

Gestational diabetes is a common medical disorder affecting around 4% of pregnancies. Risk factors include a high BMI, previous gestational diabetes, and family history of diabetes. Screening is done through an oral glucose tolerance test, and diagnostic thresholds have recently been updated. Management includes self-monitoring of blood glucose, diet and exercise advice, and medication if necessary. For pre-existing diabetes, weight loss and insulin are recommended, and tight glycemic control is important. Targets for self-monitoring include fasting glucose of 5.3 mmol/l and 1-2 hour post-meal glucose levels.

Hormone replacement therapy (HRT) is a treatment that involves administering synthetic oestrogen and progestogen to women experiencing menopausal symptoms. HRT can be given as local (creams, pessaries, rings) or systemic therapy (oral drugs, transdermal patches and gels, implants) and may contain oestrogen alone, combined oestrogen and progestogen, selective oestrogen receptor modulator, or gonadomimetics. The average age for menopause is around 50-51 years, and symptoms include hot flushes, insomnia, weight gain, mood changes, and irregular menses. HRT should be initiated at the lowest possible dosage and titrated based on clinical response. However, HRT is not recommended for women who have undergone hysterectomy due to the risk of endometrial hyperplasia, a precursor to endometrial cancer. HRT may also increase the risk of breast cancer and heart attacks, and non-hormonal options should be considered for menopausal effects in women who have previously had breast cancer. There is no evidence to suggest that HRT is associated with an increased or decreased risk of developing cervical cancer, and observational studies of systemic HRT after breast cancer are generally reassuring. Oestrogen is believed to be a growth factor that enhances cholinergic neurotransmission and prevents oxidative cell damage, neuronal atrophy, and glucocorticoid-induced neuronal damage, which may help prevent dementia.

Vaginal PGE2 is the preferred method of induction of labour, with other options such as emergency caesarean section, maternal oxytocin infusion, amniotomy, and cervical ripening balloon being considered only in certain situations. Women undergoing vaginal PGE2 should be aware of the risk of uterine hyperstimulation and may require additional analgesia. The cervix should be reassessed before considering oxytocin infusion. Amniotomy may be used in combination with oxytocin infusion in patients with a ripe cervix. Cervical ripening balloon should not be used as the primary method for induction of labour due to its potential pain, bleeding, and infection risks.

Induction of Labour: Reasons, Methods, and Complications

Induction of labour is a medical process that involves starting labour artificially. It is necessary in about 20% of pregnancies due to various reasons such as prolonged pregnancy, prelabour premature rupture of the membranes, diabetes, pre-eclampsia, and rhesus incompatibility. The Bishop score is used to assess whether induction of labour is required, which takes into account cervical position, consistency, effacement, dilation, and fetal station. A score of less than 5 indicates that labour is unlikely to start without induction, while a score of 8 or more indicates that the cervix is ripe and there is a high chance of spontaneous labour or response to interventions made to induce labour.

There are several methods of induction of labour, including membrane sweep, vaginal prostaglandin E2, maternal oxytocin infusion, amniotomy, and cervical ripening balloon. Membrane sweeping involves separating the chorionic membrane from the decidua by rotating the examining finger against the wall of the uterus. Vaginal prostaglandin E2 is the preferred method of induction of labour, unless there are specific clinical reasons for not using it. Uterine hyperstimulation is the main complication of induction of labour, which refers to prolonged and frequent uterine contractions that can cause fetal hypoxemia and acidemia. In rare cases, uterine rupture may occur, which requires removing the vaginal prostaglandins and stopping the oxytocin infusion if one has been started, and tocolysis with terbutaline.